Indian Overseas Bank Board Approves ₹5,000 Crore Capital Raising Plan for FY27

Key Metrics:

What Happened ?

Key Details

Capital Raising Plan:

• IOB approved equity fundraising of up to ₹5,000 crore.
• Fundraising can be executed through:
  • Follow-on Public Offer (FPO)
  • Rights Issue
  • Qualified Institutional Placement (QIP)
  • Preferential Issue
  • Combination of fundraising instruments
• Capital raise may occur in one or multiple tranches.
• Fundraising remains subject to statutory and shareholder approvals.
• The bank intends to strengthen capital adequacy and support business expansion.
• Capital raising flexibility allows IOB to optimize market timing and pricing.

Note:

• The diversified fundraising structure provides flexibility for the bank to access institutional and public capital markets depending on market conditions.

Tier II Bonds & Employee Share Scheme:

• IOB approved issuance of BASEL III compliant Tier II Bonds up to ₹1,000 crore.
• Bonds may be issued through:
  • Private placement
  • Public issue
  • Domestic market
  • Overseas market
• Green shoe option may be exercised depending on demand and requirements.
• The bank approved issuance of 10 crore new equity shares under IOB-ESPS 2026-27.
• Employee shares will carry face value of ₹10 each.
• Shares issued under ESPS will rank pari passu with existing equity shares.
• The ESPS applies to eligible permanent employees in India and overseas.

Note:

• The combined capital strategy supports both regulatory capital strengthening and employee ownership participation.

Balance Sheet & AGM Updates:

• The Board approved appropriation of accumulated losses as of March 31, 2026 against the share premium account.
• The adjustment remains subject to statutory approvals.
• IOB scheduled its 26th Annual General Meeting for July 7, 2026.
• AGM will be conducted through Video Conferencing / OAVM mode.
• Detailed AGM notice will be submitted separately to stock exchanges.

Note:

• The proposed balance sheet adjustment could improve reported financial presentation and strengthen future capital flexibility.

Risk Analysis

Summary:

• While the approved capital raising plan strengthens IOB’s capital position, execution risks remain linked to market conditions, shareholder approvals, dilution impact, and fundraising timing.

Key Risks:

• Large equity issuance may create near-term dilution for existing shareholders.
• Capital raising execution depends on market sentiment and investor appetite.
• Regulatory and shareholder approvals remain pending.
• Higher capital costs could impact return ratios in the short term.
• Tier II bond issuance may increase funding obligations and interest costs.
• Delay in fundraising could impact growth and capital adequacy planning.

Worst Case Scenario:

• If market conditions weaken significantly, IOB could face slower fundraising execution, pricing pressure, or lower investor participation impacting planned capital strengthening.

Company Commentary